Aberrant cytokine milieu and signaling affect immune cell phenotypes and functions in tuberculosis pathology: What can we learn from this phenomenon for application to inflammatory syndromes?
Open Access
- 25 May 2021
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Cellular & Molecular Immunology
- Vol. 18 (8), 2062-2064
- https://doi.org/10.1038/s41423-021-00695-8
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft (JA 1479/9-1, JA 1479/9-1)
- Jürgen Manchot Stiftung (MOI-3, MOI-3)
This publication has 16 references indexed in Scilit:
- Lower IL-7 Receptor Expression of Monocytes Impairs Antimycobacterial Effector Functions in Patients with TuberculosisThe Journal of Immunology, 2021
- Interleukin-6 and Mycobacterium tuberculosis dormancy antigens improve diagnosis of tuberculosisJournal of Infection, 2020
- CD27 expression of T-cells discriminates IGRA-negative TB patients from healthy contacts in GhanaMicrobes and Infection, 2020
- Suppressor of cytokine signalling 3 is crucial for interleukin‐7 receptor re‐expression after T‐cell activation and interleukin‐7 dependent proliferationEuropean Journal of Immunology, 2019
- Two-Hit in vitro T-Cell Stimulation Detects Mycobacterium tuberculosis Infection in QuantiFERON Negative Tuberculosis Patients and Healthy Contacts From GhanaFrontiers in Immunology, 2019
- Expression of STAT3-regulated genes in circulating CD4+ T cells discriminates rheumatoid arthritis independently of clinical parameters in early arthritisRheumatology, 2019
- Depressed Gamma Interferon Responses and Treatment Outcomes in Tuberculosis Patients: a Prospective Cohort StudyJournal of Clinical Microbiology, 2018
- A multi-cohort study of the immune factors associated with M. tuberculosis infection outcomesNature, 2018
- Constitutive STAT3 phosphorylation and IL-6/IL-10 co-expression are associated with impaired T-cell function in tuberculosis patientsCellular & Molecular Immunology, 2018
- Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment responseJCI Insight, 2015